恩诺沙星纸片扩散法药敏试验的拟议质量控制及解释标准
Proposed quality control and interpretive criteria for disk diffusion susceptibility testing with enoxacin.
作者信息
Rudrik J T, Cavalieri S J, Britt E M
出版信息
J Clin Microbiol. 1985 Mar;21(3):332-4. doi: 10.1128/jcm.21.3.332-334.1985.
Abstract
The standardized disk diffusion test, in which a 10-micrograms enoxacin disk is used, was performed and microbroth dilution MICs were determined to establish individual test control values with Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, Staphylococcus aureus ATCC 25923, and S. aureus ATCC 29213. In addition, regression analysis correlating inhibitory zone diameter with MICs for approximately 400 gram-negative clinical isolates was performed. Based on linear regression and error rate-bounded analyses, criteria for the category calls of isolates are proposed.
摘要
使用含10微克依诺沙星的纸片进行标准化纸片扩散试验，并测定微量肉汤稀释法的最低抑菌浓度（MIC），以建立针对大肠埃希菌ATCC 25922、铜绿假单胞菌ATCC 27853、金黄色葡萄球菌ATCC 25923和金黄色葡萄球菌ATCC 29213的个体试验对照值。此外，还对约400株革兰氏阴性临床分离株的抑菌圈直径与MIC进行了回归分析。基于线性回归和误差率受限分析，提出了分离株分类判定的标准。
相似文献
1
Proposed quality control and interpretive criteria for disk diffusion susceptibility testing with enoxacin.恩诺沙星纸片扩散法药敏试验的拟议质量控制及解释标准
J Clin Microbiol. 1985 Mar;21(3):332-4. doi: 10.1128/jcm.21.3.332-334.1985.
2
Interpretive criteria and quality control parameters for testing bacterial susceptibility to the fluoroquinolone PD131628.检测细菌对氟喹诺酮类药物PD131628敏感性的解释标准和质量控制参数。
J Clin Microbiol. 1995 Jan;33(1):235-8. doi: 10.1128/jcm.33.1.235-238.1995.
3
Evaluation of in vitro antibacterial activity of enoxacin: comparison with other orally absorbed antimicrobial agents, proposed disk diffusion test interpretive criteria, and quality control limits.依诺沙星的体外抗菌活性评估：与其他口服吸收抗菌剂的比较、提议的纸片扩散试验解释标准及质量控制限度。
Diagn Microbiol Infect Dis. 1985 May;3(3):213-21. doi: 10.1016/0732-8893(85)90033-1.
4
Quality control and interpretive criteria for the azlocillin disk diffusion susceptibility test.阿洛西林纸片扩散法药敏试验的质量控制及判读标准
Antimicrob Agents Chemother. 1982 Jul;22(1):28-31. doi: 10.1128/AAC.22.1.28.
5
Calibration of the disk diffusion test for trovafloxacin susceptibility testing of four anaerobic species.四种厌氧菌对曲伐沙星敏感性测试的纸片扩散法校准
Clin Microbiol Infect. 2000 Apr;6(4):195-201. doi: 10.1046/j.1469-0691.2000.00031.x.
6
Preliminary interpretive criteria for in vitro susceptibility testing of CP-99219 by dilution and disk diffusion methods.采用稀释法和纸片扩散法对CP-99219进行体外药敏试验的初步解释标准。
Diagn Microbiol Infect Dis. 1994 Nov;20(3):167-70. doi: 10.1016/0732-8893(94)90112-0.
7
Calibration of disk diffusion antibiotic susceptibility testing: species-related trovafloxacin interpretive zone breakpoints and selection of disk potency.纸片扩散法抗生素敏感性试验的校准：与物种相关的曲伐沙星解释性区域断点及纸片效力的选择
Scand J Infect Dis. 1999;31(6):573-8. doi: 10.1080/00365549950164463.
8
Gatifloxacin (AM-1155, CG 5501) susceptibility testing interpretive criteria and quality control guidelines for dilution and disk (5-microgram) diffusion methods. The Quality Control Study Group.加替沙星（AM - 1155，CG 5501）稀释法和纸片（5微克）扩散法药敏试验的解释标准及质量控制指南。质量控制研究组。
Diagn Microbiol Infect Dis. 1999 Apr;33(4):247-53. doi: 10.1016/s0732-8893(98)00086-8.
9
In vitro susceptibility testing and quality control parameters for sarafloxacin (A-56620): a fluoroquinolone used for treatment and control of colibacillosis in poultry. Quality Control Study Group.沙拉沙星（A-56620）的体外药敏试验及质量控制参数：一种用于治疗和控制家禽大肠杆菌病的氟喹诺酮类药物。质量控制研究组
Diagn Microbiol Infect Dis. 1998 Sep;32(1):55-64. doi: 10.1016/s0732-8893(98)00063-7.
10
Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria.氧氟沙星微量稀释法和纸片扩散法药敏试验的质量控制参数以及纸片扩散法解释标准的确认。
J Clin Microbiol. 1989 Jan;27(1):49-52. doi: 10.1128/jcm.27.1.49-52.1989.
引用本文的文献
1
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.环丙沙星：抗菌活性、药代动力学特性及治疗用途综述
Drugs. 1988 Apr;35(4):373-447. doi: 10.2165/00003495-198835040-00003.
2
Influence of medium and method on the in vitro susceptibility of Pseudomonas aeruginosa and other bacteria to ciprofloxacin and enoxacin.培养基和方法对铜绿假单胞菌及其他细菌体外对环丙沙星和依诺沙星敏感性的影响。
Antimicrob Agents Chemother. 1986 May;29(5):927-9. doi: 10.1128/AAC.29.5.927.
本文引用的文献
1
In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid.新型吡啶羧酸AT-2266的体外抗菌特性
Antimicrob Agents Chemother. 1983 May;23(5):641-8. doi: 10.1128/AAC.23.5.641.
2
In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim.喹诺酮羧酸依诺沙星的体外活性与诺氟沙星、新型β-内酰胺类、氨基糖苷类及甲氧苄啶的体外活性比较。
Antimicrob Agents Chemother. 1983 Nov;24(5):754-63. doi: 10.1128/AAC.24.5.754.
3
In vitro and in vivo antibacterial activity of AT-2266.AT-2266的体外和体内抗菌活性
Antimicrob Agents Chemother. 1983 Jul;24(1):78-84. doi: 10.1128/AAC.24.1.78.
4
In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound.口服抗假单胞菌化合物CI-919（AT-2266）的体外活性
Antimicrob Agents Chemother. 1983 May;23(5):658-63. doi: 10.1128/AAC.23.5.658.
5
Susceptibility tests of anaerobic bacteria: statistical and clinical considerations.厌氧菌药敏试验：统计学与临床考量
J Infect Dis. 1974 Dec;130(6):588-94. doi: 10.1093/infdis/130.6.588.
Zotero 插件